Walleye Capital’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$402K Sell
7,700
-1,500
-16% -$90K ﹤0.01% 2827
2025
Q4
$541K Sell
9,200
-4,900
-35% -$298K ﹤0.01% 2916
2025
Q3
$784K Buy
14,100
+2,700
+24% +$145K ﹤0.01% 2284
2025
Q2
$587K Buy
+11,400
New +$573K ﹤0.01% 2502
2024
Q4
Sell
-100
Closed -$7.99K 5545
2024
Q3
$7.99K Sell
100
-1,800
-95% -$135K ﹤0.01% 4945
2024
Q2
$136K Sell
1,900
-200
-10% -$14.7K ﹤0.01% 4550
2024
Q1
$148K Sell
2,100
-200
-9% -$14.3K ﹤0.01% 4164
2023
Q4
$177K Buy
+2,300
New +$151K ﹤0.01% 3746
2023
Q3
Sell
-1,100
Closed -$89.8K 5320
2023
Q2
$89.8K Sell
1,100
-400
-27% -$32.2K ﹤0.01% 3469
2023
Q1
$111K Buy
+1,500
New +$116K ﹤0.01% 2869

Other funds holding TECH

Walleye Capital's TECH Position: Q1 2026 in Review

Walleye Capital reduced its Bio-Techne (TECH) stake by 5.7% in Q1 2026, selling an estimated $484K and leaving 132,407 shares worth $6.92M. The position accounts for 0.03% of the portfolio, ranked #599.

Walleye Capital first reported a position in TECH in Q1 2022 and has held it in 10 quarters since. The position peaked at $24.7M in Q3 2025. 582 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • Walleye Capital held 132,407 shares of Bio-Techne worth $6.92M as of Q1 2026.
  • Walleye Capital sold 8,061 Bio-Techne shares in Q1 2026, an estimated $484K.
  • Bio-Techne made up 0.03% of Walleye Capital's portfolio in Q1 2026, its #599 holding.
  • Walleye Capital first reported a position in Bio-Techne in Q1 2022 and has held it in 10 quarters since.
  • Walleye Capital's Bio-Techne position peaked at $24.7M in Q3 2025.
  • 582 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.